Page last updated: 2024-10-30

ketotifen and Genital Neoplasms, Female

ketotifen has been researched along with Genital Neoplasms, Female in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Genital Neoplasms, Female: Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
The, FO1
Buist, MR1
Lei, A1
Bennink, RJ1
Hofland, J1
van den Wijngaard, RM1
de Jonge, WJ1
Boeckxstaens, GE1

Trials

1 trial available for ketotifen and Genital Neoplasms, Female

ArticleYear
The role of mast cell stabilization in treatment of postoperative ileus: a pilot study.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:9

    Topics: Adult; Aged; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Transit; Genital Neopla

2009